Neurobiology of Aging
Volume 33, Issue 1 , Pages 200.e11-200.e22 , January 2012

Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1−/− mice

  • Andras Bilkei-Gorzo

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • Corresponding Author InformationCorresponding author at: Institute of Molecular Psychiatry, University of Bonn, Sigmund-Freud-str. 25, 53127 Bonn, Germany. Tel.: +49 228 6885 317
    • ,
  • Eva Drews

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Önder Albayram

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Anastasia Piyanova

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Evelyn Gaffal

      Affiliations

    • Clinic of Dermatology and Allergology, University of Bonn, Bonn, Germany
    • ,
  • Thomas Tueting

      Affiliations

    • Clinic of Dermatology and Allergology, University of Bonn, Bonn, Germany
    • ,
  • Kerstin Michel

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Daniela Mauer

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Wolfgang Maier

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
    • ,
  • Andreas Zimmer

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany

Received 21 January 2010 ,Revised 2 July 2010 ,Accepted 9 July 2010.

References 

  1. Ahima RS, Bjorbaek C, Osei S, Flier JS. Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology. 1999;140:2755–2762
  2. Baltes PB, Lindenberger U. Emergence of a powerful connection between sensory and cognitive functions across the adult life span: a new window to the study of cognitive aging?. Psychol. Aging. 1997;12:12–21
  3. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 1992;31:119–130
  4. Berrendero F, Romero J, Garcia-Gil L, Suarez I, De la Cruz P, Ramos JA, et al. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta. 1998;1407:205–214
  5. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A, Klingmuller D. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology. 2004;176:343–352
  6. Bilkei-Gorzo A, Racz I, Valverde O, Otto M, Michel K, Sastre M, et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl. Acad. Sci. U. S. A. 2005;102:15670–15675
  7. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464:529–535
  8. Cacciola G, Chioccarelli T, Mackie K, Meccariello R, Ledent C, Fasano S, et al. Expression of type 1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiation. Biol. Reprod. 2008;79:758–765
  9. Cervos-Navarro J, Diemer NH. Selective vulnerability in brain hypoxia. Crit. Rev. Neurobiol. 1991;6:149–182
  10. Chigurupati S, Son TG, Hyun DH, Lathia JD, Mughal MR, Savell J, et al. Lifelong running reduces oxidative stress and degenerative changes in the testes of mice. J. Endocrinol. 2008;199:333–341
  11. Cohen E, Dillin A. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat. Rev. Neurosci. 2008;9:759–767
  12. Coleman S, Saboeiro A, Sengelmann R. A comparison of lipoatrophy and aging: volume deficits in the face. Aesthet. Plast. Surg. 2009;33:14–21
  13. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 2007;148:1574–1581
  14. Dao H, Kazin RA. Gender differences in skin: a review of the literature. Gend. Med. 2007;4:308–328
  15. Dean RL, Scozzafava J, Goas JA, Regan B, Beer B, Bartus RT. Age-related differences in behavior across the life span of the C57BL/6J mouse. Exp. Aging Res. 1981;7:427–451
  16. Ding DL, McFadden SL, Wang J, Hu BH, Salvi RJ. Age- and strain-related differences in dehydrogenase activity and glycogen levels in CBA and C57 mouse cochleas. Audiol. Neuro Otol. 1999;4:55–63
  17. Fernandez-Ruiz J, de Miguel R, Hernandez M, Cebeira M, Ramos JA. Endocannabinoids and dopamine-related functions in the CNS. In:  Onaivi ES,  Sugiura T,  Di Marzo V editor. Endocannabinoids (The Brain and Body's Marijuana and Beyond). Boca Raton: CRC Press; 2006;p. 261–290
  18. Gallagher M, Nicolle MM. Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry. Behav. Brain Res. 1993;57:155–162
  19. Garcia-Arencibia M, Gonzalez S, de Lago E, Ramos JA, Mechoulam R, Fernandez-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 2007;1134:162–170
  20. Grady CL, Craik FI. Changes in memory processing with age. Curr. Opin. Neurobiol. 2000;10:224–231
  21. Griebel G, Stemmelin J, Scatton B. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol. Psychiatry. 2005;57:261–267
  22. Grundy RI, Rabuffetti M, Beltramo M. Cannabinoids and neuroprotection. Mol. Neurobiol. 2001;24:29–51
  23. Hajos N, Ledent C, Freund TF. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience. 2001;106:1–4
  24. Haller J, Bakos N, Szirmay M, Ledent C, Freund TF. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur. J. Neurosci. 2002;16:1395–1398
  25. Hampson AJ, Grimaldi M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur. J. Neurosci. 2001;13:1529–1536
  26. Harburger LL, Lambert TJ, Frick KM. Age-dependent effects of environmental enrichment on spatial reference memory in male mice. Behav. Brain Res. 2007;185:43–48
  27. Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J. Aging and genome maintenance: lessons from the mouse?. Science. 2003;299:1355–1359
  28. Hekimi S, Guarente L. Genetics and the specificity of the aging process. Science. 2003;299:1351–1354
  29. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci. 2006;26:1343–1354
  30. Inoue M, Suhara T, Sudo Y, Okubo Y, Yasuno F, Kishimoto T, et al. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci. 2001;69:1079–1084
  31. Ison JR, Allen PD, O'Neill WE. Age-related hearing loss in C57BL/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J. Assoc. Res. Otolaryngol. 2007;8:539–550
  32. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur. Respir. J. 1999;13:197–205
  33. Jennings JM, Jacoby LL. An opposition procedure for detecting age-related deficits in recollection: telling effects of repetition. Psychol. Aging. 1997;12:352–361
  34. Kahan V, Andersen ML, Tomimori J, Tufik S. Stress, immunity and skin collagen integrity: evidence from animal models and clinical conditions. Brain Behav. Immun. 2009;23:1089–1095
  35. Kim HJ, Waataja JJ, Thayer SA. Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 2008;325:850–858
  36. Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. J. Pharmacol. Exp. Ther. 2005;313:88–94
  37. Knaggs H. A new source of aging?. J. Cosmet. Dermatol. 2009;8:77–82
  38. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829–1833
  39. Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology. 1995;119:282–290
  40. Lichtman AH, Varvel SA, Martin BR. Endocannabinoids in cognition and dependence (Prostaglandins Leukot). Essent. Fatty Acids. 2002;66:269–285
  41. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. U. S. A. 2003;100:8526–8531
  42. Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126:257–268
  43. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, et al. The endocannabinoid system in human keratinocytes (Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein 1, and transglutaminase). J. Biol. Chem. 2003;278:33896–33903
  44. Maccarrone M, Valverde O, Barbaccia ML, Castane A, Maldonado R, Ledent C, et al. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur. J. Neurosci. 2002;15:1178–1186
  45. Magri F, Cravello L, Barili L, Sarra S, Cinchetti W, Salmoiraghi F, et al. Stress and dementia: the role of the hypothalamicpituitary-adrenal axis. Aging Clin. Exp. Res. 2006;18:167–170
  46. Marighetto A, Valerio S, Desmedt A, Philippin JN, Trocme-Thibierge C, Morain P. Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice. Psychopharmacology (Berl). 2008;197:499–508
  47. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418:530–534
  48. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology. 2002;159:379–387
  49. Morley JE. Decreased food intake with aging. J. Gerontol. A Biol. Sci. Med. Sci. 2001;56:81–88
  50. Mowrey RA, Hershberger TV. Effect of age and body weight on the maintenance requirement of lean and obese Zucker rats. J. Nutr. 1982;112:2116–2121
  51. Muir JL, Fischer W, Bjorklund A. Decline in visual attention and spatial memory in aged rats. Neurobiol. Aging. 1999;20:605–615
  52. Murphy GG, Shah V, Hell JW, Silva AJ. Investigation of age-related cognitive decline using mice as a model system: neurophysiological correlates. Am. J. Geriatr. Psychiatry. 2006;14:1012–1021
  53. Nava F, Carta G, Colombo G, Gessa GL. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology. 2001;41:392–399
  54. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006;444:1038–1043
  55. Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog. Neurobiol. 2009;89:369–382
  56. Ohlemiller KK, Lett JM, Gagnon PM. Cellular correlates of age-related endocochlear potential reduction in a mouse model. Hear. Res. 2006;220:10–26
  57. Onaivi ES, Ishiguro H, Wu Zhang P, Lin Z, Akinshola BE, Leonard CM, et al. Endocannabinoid receptor genetics and marijuana use. In:  Onaivi ES,  Sugiura T,  Di Marzo V editor. Endocannabinoids (The Brain and Body's Marijuana and Beyond). Boca Raton: CRC Press; 2006;
  58. Palanza P, Morley-Fletcher S, Laviola G. Novelty seeking in periadolescent mice: sex differences and influence of intrauterine position. Physiol. Behav. 2001;72:255–262
  59. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001;413:527–531
  60. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 1985;63:29–37
  61. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 2004;28:640–648
  62. Reggio PH. The relationship between endocannabinoid conformation and endocannabinoid interaction at the cannabinoid receptors. In:  Onaivi ES,  Sugiura T,  Di Marzo V editor. Endocannabinoids (The Brain and Body's Marijuana and Beyond). Boca Raton: CRC Press; 2006;
  63. Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A. Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol. 1999;379:R1–R2
  64. Romero J, Berrendero F, Garcia-Gil L, de la Cruz P, Ramos JA, Fernandez-Ruiz JJ. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5′O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience. 1998;84:1075–1083
  65. Sava V, Reunova O, Velasquez A, Song S, Sanchez-Ramos J. Neuroanatomical mapping of DNA repair and antioxidative responses in mouse brain: Effects of a single dose of MPTP. Neurotoxicology. 2006;27:1080–1093
  66. Scarpace PJ, Matheny M, Shek EW. Impaired leptin signal transduction with age-related obesity. Neuropharmacology. 2000;39:1872–1879
  67. Schuel H, Burkman LJ. Endocannabinoid receptor genetics and marijuana use. In:  Onaivi ES,  Sugiura T,  Di Marzo V editor. Endocannabinoids (The Brain and Body's Marijuana and Beyond). Boca Raton: CRC Press; 2006;
  68. Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol. 1998;54:459–462
  69. Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 2000;278:157–160
  70. Skaper SD, Floreani M, Ceccon M, Facci L, Giusti P. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann. N.Y. Acad. Sci. 1999;890:107–118
  71. Sommer M, Poliak N, Upadhyay S, Ratovitski E, Nelkin BD, Donehower LA, et al. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle. 2006;5:2005–2011
  72. Spongr VP, Flood DG, Frisina RD, Salvi RJ. Quantitative measures of hair cell loss in CBA and C57BL/6 mice throughout their life spans. J. Acoust. Soc. Am. 1997;101:3546–3553
  73. Steiner MA, Wanisch K, Monory K, Marsicano G, Borroni E, Bachli H, et al. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008;8:196–208
  74. Steiner MA, Wotjak CT. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 2008;170:397–432
  75. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, et al. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology. 1996;126:165–172
  76. Thiebot M-H, Chaperon F, Fride E, Onaivi ES. Behavioral effects of endocannabinoids. In:  Onaivi ES,  Sugiura T,  Di Marzo V editor. Endocannabinoids (The Brain and Body's Marijuana and Beyond). Boca Raton: CRC Press; 2006;
  77. Thiemann G, Watt CA, Ledent C, Molleman A, Hasenohrl RU. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav. Brain Res. 2009;200:60–67
  78. Tomas-Loba A, Flores I, Fernandez-Marcos PJ, Cayuela ML, Maraver A, Tejera A, et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell. 2008;135:609–622
  79. Tou JC, Wade CE. Determinants affecting physical activity levels in animal models. Exp. Biol. Med. Maywood. 2002;227:587–600
  80. Tower J. Sex-specific regulation of aging and apoptosis. Mech. Ageing Dev. 2006;127:705–718
  81. Troiano NW, Ciovacco WA, Kacena MA. The effects of fixation and dehydration on the histological quality of undecalcified murine bone specimens embedded in methylmethacrylate. J. Histotechnol. 2009;32:27–31
  82. Underdown NJ, Hiley CR, Ford WR. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br. J. Pharmacol. 2005;146:809–816
  83. Van Eyken E, Van Camp G, Van Laer L. The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol. Neuro Otol. 2007;12:345–358
  84. Varvel SA, Lichtman AH. Evaluation of CB1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 2002;301:915–924
  85. Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, et al. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J. Neurosci. 2003;23:4127–4133
  86. Verhaeghen P, Cerella J. Aging, executive control, and attention: a review of meta-analyses. Neurosci. Biobehav. Rev. 2002;26:849–857
  87. Viveros MP, de Fonseca FR, Bermudez-Silva FJ, McPartland JM. Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications. Endocrinol. Metab. Immune Disord. Drug Targets. 2008;8:220–230
  88. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U. S. A. 2003;100:1393–1398
  89. Wang X, Pal R, Chen XW, Limpeanchob N, Kumar KN, Michaelis EK. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Brain Res. Mol. Brain Res. 2005;140:120–126
  90. Weller A, Leguisamo AC, Towns L, Ramboz S, Bagiella E, Hofer M, et al. Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Dev. Psychobiol. 2003;42:194–205
  91. Willott JF. Effects of aging, hearing loss, and anatomical location on thresholds of inferior colliculus neurons in C57BL/6 and CBA mice. J. Neurophysiol. 1986;56:391–408
  92. Wolff MC, Leander JD. SR 141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur. J. Pharmacol. 2003;477:213–217
  93. Wong ND, Kouwabunpat D, Vo AN, Detrano RC, Eisenberg H, Goel M, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am. Heart J. 1994;127:422–430
  94. Zhao H, Li Q, Pei X, Zhang Z, Yang R, Wang J, et al. Long-term ginsenoside administration prevents memory impairment in aged C57BL/6J mice by up-regulating the synaptic plasticity-related proteins in hippocampus. Behav. Brain Res. 2009;201:311–317
  95. Zheng Y, Baek JH, Smith PF, Darlington CL. Cannabinoid receptor down-regulation in the ventral cochlear nucleus in a salicylate model of tinnitus. Hear. Res. 2007;228:105–111

PII: S0197-4580(10)00317-9

doi: 10.1016/j.neurobiolaging.2010.07.009

Neurobiology of Aging
Volume 33, Issue 1 , Pages 200.e11-200.e22 , January 2012

Article Tools

* Image Usage & Resolution